Objective: High neutrophil/lymphocyte ratio (NLR) is associated with high mortality and recurrence in various types of malignancy. Studies on the prognosis of benign masses in the literature are quite rare. The aim of this study was to investigate the association of preoperative NLR with recurrence in paranasal sinus mucoceles.
Material and Methods: Demographic characteristics, hemogram values, distribution of mucoceles in paranasal sinuses, complaints of the patients, and their follow-up periods were retrospectively analyzed in patients with paranasal sinus mucocele at a tertiary care center between 2010 and 2017. Fischer’s exact test and Mann–Whitney U test were used for statistical analyses.
Results: A total of 53 patients (25 females and 28 males) were operated. The preoperative NLRs were 1.92 (standard deviation (SD)=0.97), –2.15 (SD=1.07), and –1.99 (SD=1.08) for the frontoethmoid, maxillary, and sphenoid sinuses, respectively. After 24 months of follow-up (range, 14–84 months), recurrence was detected in four patients for the sphenoid sinus mucocele and in five patients for the frontoethmoid sinus mucocele. The mean recurrence time was 10 months. No statistically significant difference was found between the frontal and sphenoid sinus sites in terms of recurrence (p=2.15). The preoperative NLR of the patients with recurrence was found to be 2.39 (p=0.352) for mucoceles located in the sphenoid sinus and 3.106 (p=0.019) for mucoceles located in the frontoethmoid region.
Conclusion: Preoperative high NLR can be used to show recurrence in the paranasal mucoceles of the frontoethmoid region. NLR is an inexpensive marker that is easily obtained from routine blood samples and may lead the clinician in the prognosis of frontoethmoid sinus mucocele patients.
| Primary Language | English |
|---|---|
| Subjects | Otorhinolaryngology |
| Journal Section | Research Article |
| Authors | |
| Publication Date | December 7, 2019 |
| Published in Issue | Year 2019 Volume: 2 Issue: 3 |
You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104
Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.